Richard A Meier - Net Worth and Insider Trading
Richard A Meier Net Worth
The estimated net worth of Richard A Meier is at least $18 Million dollars as of 2024-04-18. Richard A Meier is the Director of Biomarin Pharmaceutical Inc and owns about 104,014 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $9 Million. Richard A Meier is the Exec. Vice Pres. and CFO of Teleflex Inc and owns about 20,147 shares of Teleflex Inc (TFX) stock worth over $4 Million. Richard A Meier is also the EVP & CFO of Intersect ENT Inc and owns about 124,471 shares of Intersect ENT Inc (XENT) stock worth over $4 Million. Besides these, Richard A Meier also holds Staar Surgical Co (STAA) . Details can be seen in Richard A Meier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard A Meier has not made any transactions after 2022-05-02 and currently still holds the listed stock(s).
Transaction Summary of Richard A Meier
Richard A Meier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard A Meier owns 6 companies in total, including Biomarin Pharmaceutical Inc () , Intersect ENT Inc () , and Owens & Minor Inc () among others .
Click here to see the complete history of Richard A Meier’s form 4 insider trades.
Insider Ownership Summary of Richard A Meier
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Biomarin Pharmaceutical Inc | 2022-05-02 | director | |
Intersect ENT Inc | 2020-03-17 | EVP & Chief Financial Officer | |
Owens & Minor Inc | 2013-03-01 | EVP & Chief Financial Officer | |
Staar Surgical Co | 2016-05-20 | director | |
Teleflex Inc | 2010-03-19 | Exec. Vice Pres. and CFO | |
Rockley Photonics Holdings Ltd | 2022-10-20 | President & CFO |
Richard A Meier Latest Holdings Summary
Richard A Meier currently owns a total of 4 stocks. Among these stocks, Richard A Meier owns 104,014 shares of Biomarin Pharmaceutical Inc (BMRN) as of May 2, 2022, with a value of $9 Million and a weighting of 52.37%. Richard A Meier owns 20,147 shares of Teleflex Inc (TFX) as of March 19, 2010, with a value of $4 Million and a weighting of 23.35%. Richard A Meier also owns 124,471 shares of Intersect ENT Inc (XENT) as of March 17, 2020, with a value of $4 Million and a weighting of 19.56%. The other 1 stocks Staar Surgical Co (STAA) have a combined weighting of 4.72% among all his current holdings.
Latest Holdings of Richard A Meier
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BMRN | Biomarin Pharmaceutical Inc | 2022-05-02 | 104,014 | 90.47 | 9,410,147 |
TFX | Teleflex Inc | 2010-03-19 | 20,147 | 208.30 | 4,196,620 |
XENT | Intersect ENT Inc | 2020-03-17 | 124,471 | 28.24 | 3,515,061 |
STAA | Staar Surgical Co | 2016-05-20 | 18,300 | 46.30 | 847,290 |
Holding Weightings of Richard A Meier
Richard A Meier Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard A Meier has made a total of 2 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 3,878 shares on May 2, 2022, which brought Richard A Meier around $318,345.
According to the SEC Form 4 filings, Richard A Meier has made a total of 0 transactions in Teleflex Inc (TFX) over the past 5 years. The most-recent trade in Teleflex Inc is the acquisition of 5,000 shares on March 19, 2010, which cost Richard A Meier around $315,500.
According to the SEC Form 4 filings, Richard A Meier has made a total of 2 transactions in Intersect ENT Inc (XENT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Intersect ENT Inc is the acquisition of 5,000 shares on March 17, 2020, which cost Richard A Meier around $39,000.
More details on Richard A Meier's insider transactions can be found in the Insider Trading History of Richard A Meier table.Insider Trading History of Richard A Meier
- 1
Richard A Meier Trading Performance
GuruFocus tracks the stock performance after each of Richard A Meier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard A Meier is 23.65%. GuruFocus also compares Richard A Meier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard A Meier within 3 months outperforms 6 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard A Meier's insider trading performs compared to the benchmark.
Performance of Richard A Meier
Average Relative Return
77.74%
Outperforming Transactions
89%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 14.34 | 23.65 | 46.92 | 77.74 | 51.13 | 32.35 |
Relative Return to S&P 500(%) | 5.94 | 8.3 | 26.84 | 45.54 | 30.63 | 17.87 |
Richard A Meier Ownership Network
Ownership Network List of Richard A Meier
Ownership Network Relation of Richard A Meier
Richard A Meier Owned Company Details
What does Biomarin Pharmaceutical Inc do?
Who are the key executives at Biomarin Pharmaceutical Inc?
Richard A Meier is the director of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include director & Chief Executive Officer Jean Jacques Bienaime , GVP & Chief Accounting Officer Erin Burkhart , and VP & General Counsel George Eric Davis .
Biomarin Pharmaceutical Inc () Insider Trades Summary
Over the past 18 months, Richard A Meier made no insider transaction in Biomarin Pharmaceutical Inc (). Other recent insider transactions involving Biomarin Pharmaceutical Inc () include a net sale of 291,000 shares made by Jean Jacques Bienaime , a net sale of 61,000 shares made by Jeffrey Robert Ajer , and a net sale of 17,380 shares made by Brian Mueller .
In summary, during the past 3 months, insiders sold 139,229 shares of Biomarin Pharmaceutical Inc () in total and bought 0 shares, with a net sale of 139,229 shares. During the past 18 months, 482,233 shares of Biomarin Pharmaceutical Inc () were sold and 3,625 shares were bought by its insiders, resulting in a net sale of 478,608 shares.
Biomarin Pharmaceutical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomarin Pharmaceutical Inc Insider Transactions
Richard A Meier Mailing Address
Above is the net worth, insider trading, and ownership report for Richard A Meier. You might contact Richard A Meier via mailing address: C/o Intersect Ent, Inc., 1555 Adams Drive, Menlo Park Ca 94025.